Search

Your search keyword '"Stage III melanoma"' showing total 5 results
Start Over Descriptor "Stage III melanoma" Language french
5 results on '"Stage III melanoma"'

1. [New guidelines for stage III melanoma (the French Cutaneous Oncology Group)]

Author

E. Desmedt, M.-T. Leccia, Marc Pracht, A. Dupuy, Bernard Guillot, Géraldine Jeudy, Thomas Jouary, Elif Hindié, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Pathogénèse et contrôle des infections chroniques (PCCI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), CHU Pontchaillou [Rennes], Département d'oncologie médicale [Rennes], CRLCC Eugène Marquis (CRLCC), Centre Eugène Marquis (CRLCC), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Service de Dermatologie (CHU de Dijon), CHU Bordeaux [Bordeaux], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre hospitalier de Pau, Centre Hospitalier Universitaire [Grenoble] (CHU), and CCSD, Accord Elsevier

Subjects
Oncology, medicine.medical_specialty, medicine.medical_treatment, Immunothérapie, Recommandations, Dermatology, Guidelines, Targeted therapy, Mélanome stade III, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Stage III melanoma, Internal medicine, medicine, business.industry, Sentinel node, [SDV.MHEP.DERM] Life Sciences [q-bio]/Human health and pathology/Dermatology, 3. Good health, Clinical trial, Ganglion sentinelle, Immunotherapy, business, [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology, Thérapie ciblée
Abstract

International audience; Improved knowledge of sentinel node procedures coupled with the results of adjuvant clinical trials in stage III melanoma have prompted the French Cutaneous Oncology Group to propose new guidelines for the management of stage III melanoma. These guidelines comply with the principles of the evidence-based medicine.

Published
2019

2. Republication de : Actualisation des données concernant le mélanome stade III : nouvelles recommandations du groupe français de cancérologie cutanée

Author

Marc Pracht, E. Desmedt, Géraldine Jeudy, Bernard Guillot, Marie-Thérèse Leccia, Elif Hindié, Thomas Jouary, Alain Dupuy, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Service de Dermatologie [Rennes] = Dermatology [Rennes], CHU Pontchaillou [Rennes], CRLCC Eugène Marquis (CRLCC), Service de Dermatologie (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Service de médecine nucléaire [Bordeaux], CHU de Bordeaux Pellegrin [Bordeaux], and Centre Hospitalier Universitaire [Grenoble] (CHU)

Subjects
0301 basic medicine, Gynecology, Cancer Research, medicine.medical_specialty, business.industry, [SDV]Life Sciences [q-bio], Hematology, General Medicine, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, medicine, Radiology, Nuclear Medicine and imaging, Stage III melanoma, Mélanome stade IIIThérapie cibléeImmunothérapieGanglion sentinelleRecommandations, business
Abstract

International audience; Les résultats des études sur le ganglion sentinelle et des essais de thérapies ciblées ou d’immunothérapie en situation adjuvante dans le mélanome ont rendu indispensable une actualisation des recommandations de prise en charge des mélanomes de stade III. À la demande du Groupe de cancérologie cutanée de la Société française de dermatologie, une actualisation a donc été réalisée en utilisant les méthodes classiques d’analyse de la littérature selon les principes de la médecine fondée sur les preuves.

Published
2019

3. Actualisation des données concernant le mélanome stade III : nouvelles recommandations du groupe français de cancérologie cutanée

Author

Guillot, B., Dupuy, A., Pracht, M., Jeudy, G., Hindie, E., Desmedt, E., Jouary, T., Leccia, M.-T., Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Pathogénèse et contrôle des infections chroniques (PCCI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), CHU Pontchaillou [Rennes], Département d'oncologie médicale [Rennes], CRLCC Eugène Marquis (CRLCC), Centre Eugène Marquis (CRLCC), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Service de Dermatologie (CHU de Dijon), CHU Bordeaux [Bordeaux], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre hospitalier de Pau, and Centre Hospitalier Universitaire [Grenoble] (CHU)

Subjects
Skin Neoplasms, Immunothérapie, Recommandations, Guidelines, Mélanome stade III, Ganglion sentinelle, Targeted therapy, Sentinel node, Stage III melanoma, Humans, Immunotherapy, Melanoma, [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology, Thérapie ciblée, Neoplasm Staging
Abstract

International audience; Improved knowledge of sentinel node procedures coupled with the results of adjuvant clinical trials in stage III melanoma have prompted the French Cutaneous Oncology Group to propose new guidelines for the management of stage III melanoma. These guidelines comply with the principles of the evidence-based medicine.

Published
2018

4. [Reprint of: New guidelines for stage III melanoma (the French Cutaneous Oncology Group)].

Author

Guillot B, Dupuy A, Pracht M, Jeudy G, Hindie E, Desmedt E, Jouary T, and Leccia MT

Abstract

Improved knowledge of sentinel node procedures coupled with the results of adjuvant clinical trials in stage III melanoma have prompted the French Cutaneous Oncology Group to propose new guidelines for the management of stage III melanoma. These guidelines comply with the principles of the evidence-based medicine., (Copyright © 2019 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.)

Published
2019
Full Text
View/download PDF

5. [New guidelines for stage III melanoma (the French Cutaneous Oncology Group)].

Author

Guillot B, Dupuy A, Pracht M, Jeudy G, Hindie E, Desmedt E, Jouary T, and Leccia MT

Subjects
Humans, Neoplasm Staging, Melanoma pathology, Skin Neoplasms pathology
Abstract

Improved knowledge of sentinel node procedures coupled with the results of adjuvant clinical trials in stage III melanoma have prompted the French Cutaneous Oncology Group to propose new guidelines for the management of stage III melanoma. These guidelines comply with the principles of the evidence-based medicine., (Copyright © 2019 Elsevier Masson SAS. All rights reserved.)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results